DOI:
10.1055/s-00000004
Aktuelle Neurologie
LinksClose Window
References
LeWitt PA, Ondo WG, Van Lunen B. et al
Open-label study assessment of safety and adverse effects of
subcutaneous apomorphine injections in treating „off” episodes in
advanced Parkinson disease.
Clin Neuropharmacol. 2009; 32: 89-93
We do not assume any responsibility for the contents of the web pages of other providers.